Kupffer cell products and interleukin 1β directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes

Innate Immunity

Volumn 14, Issue 4, 2008, Pages 255-266

  Bartolomé, Nerea ^a   Arteta, Beatriz ^a   Martínez, María José ^a   Chico, Yolanda ^a   Ochoa, Begoña ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

apoB translational regulation; Kupffer cell products; Phospholipid secretion; Pro inflammatory cytokine; Septic VLDL

Indexed keywords

APOLIPOPROTEIN B; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; PHOSPHOLIPID; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN B100; LIPOPOLYSACCHARIDE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMORAL IMMUNITY; KUPFFER CELL; LIPOGENESIS; LIPOPROTEIN SECRETION; LIVER CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SEPSIS; UPREGULATION; ANIMAL; BIOSYNTHESIS; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG EFFECT; DRUG POTENTIATION; ENDOTOXEMIA; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHAGOCYTOSIS; SECRETION; SPRAGUE DAWLEY RAT;

NEGIBACTERIA; RATTUS; RODENTIA;

ANIMALS; APOLIPOPROTEIN B-100; CELL CULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENDOTOXEMIA; FEMALE; HEPATOCYTES; HUMANS; INTERLEUKIN-1BETA; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, VLDL; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 58949097266     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425908094718     Document Type: Article

References (59)

1. Hoedemakers RM, Morselt HW, Scherphof GL, Daemen T. Heterogeneity in secretory responses of rat liver macrophages of different size. Liver 1995; 15: 313-319.
2. Bilzer M., Roggel F., Gerbes AL Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175-1186.
3. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192: 245-261.
4. Ramadori G., Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999; 19: 141-155.
5. Khovidhunkit W., Kim MS, Memon RA et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 2004; 45: 1169-1196.
6. Esteve E., Ricart W., Fernandez-Real JM Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005; 24: 16-31.
7. Lanza-Jacoby S., Phetteplace H., Sedkova N., Knee G. Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor α during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia. Shock 1998; 9: 46-51.
8. Hardardottir I., Grunfeld C., Feingold KR Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 1994; 5: 207-215.
9. Feingold KR, Staprans I., Memon RA et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: Low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 1992; 33: 1765-1776.
10. Aspichueta P., Perez S., Ochoa B., Frenedo O. Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver. J Lipid Res 2005; 46: 1017-1026.
11. Harris HW, Gosnell JE, Kumwenda ZL The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000; 6: 421-430.
12. Harris HW, Kasravi FB Lipoprotein-bound LPS induces cytokine tolerance in hepatocytes. J Endotoxin Res 2003; 9: 45-50.
13. Feingold KR, Grunfeld C. Lipoproteins: Are they important components of host defense? Hepatology 1997; 26: 1685-1686.
14. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986; 83: 2704-2708.
15. Ruttinger D., Vollmar B., Wanner GA, Messmer K. In vivo assessment of hepatic alterations following gadolinium chloride-induced Kupffer cell blockade. J Hepatol 1996; 25: 960-967.
16. Neyrinck AM, Taper HS, Gevers V., Declerck B., Delzenne NM Inhibition of Kupffer cell activity induces hepatic triglyceride synthesis in fasted rats, independent of lipopolysaccharide challenge. J Hepatol 2002; 36: 466-473.
17. Davidson NO, Shelness GS Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev Nutr 2000; 20: 169-193.
18. Hussain MM, Shi J., Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 2003; 44: 22-32.
19. Liang JS, Ginsberg HN Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells. J Biol Chem 2001; 276: 28606-28612.
20. Pullinger CR, North JD, Teng BB et al. The apolipoprotein B gene is constitutively expressed in HepG2 cells: Regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 1989; 30: 1065-1077.
21. Fisher EA, Ginsberg HN Complexity in the secretory pathway: The assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem 2002; 277: 17377-17380.
22. Sidiropoulos KG, Pontrelli L., Adeli K. Insulin-mediated suppression of apolipoprotein B mRNA translation requires the 5′ UTR and is characterized by decreased binding of an insulin-sensitive 110-kDa 5′ UTR RNA-binding protein. Biochemistry 2005; 44: 12572-12581.
23. Pontrelli L., Sidiropoulos KG, Adeli K. Translational control of apolipoprotein B mRNA: Regulation via cis elements in the 5′ and 3′ untranslated regions. Biochemistry 2004; 43: 6734-6744.
24. Singh K., Batuman OA, Akman HO, Kedees MH, Vakil V., Hussain MM Differential, tissue-specific, transcriptional regulation of apolipoprotein B secretion by transforming growth factor β. J Biol Chem 2002; 277: 39515-39524.
25. Perez S., Aspichueta P., Ochoa B., Chico Y. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. Biochim Biophys Acta 2006; 1761: 160-171.
26. Aspichueta P., Perez-Agote B., Perez S., Ochoa B., Fresnedo O. Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver. J Endotoxin Res 2006; 12: 181-192.
27. Bartolome N., Rodriguez L., Martinez MJ, Ochoa B., Chico Y. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-α in rat hepatocyte cultures in the absence of extracellular fatty acids. Ann NY Acad Sci 2007; 1096: 55-69.
28. Yokoyama K., Ishibashi T., Yi-qiang L., Nagayoshi A., Teramoto T., Maruyama Y. Interleukin-1β and interleukin-6 increase levels of apolipoprotein B mRNA and decrease accumulation of its protein in culture medium of HepG2 cells. J Lipid Res 1998; 39: 103-113.
29. Jura J., Wegrzyn P., Zarebski A., Wladyka B., Koj A. Identification of changes in the transcriptome profile of human hepatoma HepG2 cells stimulated with interleukin-1β. Biochim Biophys Acta 2004; 1689: 120-133.
30. Adi S., Pollock AS, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Role for monokines in the metabolic effects of endotoxin. Interferon-γ restores responsiveness of C3H/HeJ mice in vivo. J Clin Invest 1992; 89: 1603-1609.
31. Feingold KR, Soued M., Serio MK, Moser AH, Dinarello CA, Grunfeld C. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 1989; 125: 267-274.
32. Nonogaki K., Fuller GM, Fuentes NL et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995; 136: 2143-2149.
33. Feingold KR, Soued M., Adi S. et al. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. Arterioscler Thromb 1991; 11: 495-500.
34. Greenberg AS, Nordan RP, McIntosh J., Calvo JC, Scow RO, Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin 6 in cancer cachexia. Cancer Res 1992; 52: 4113-4116.
35. Feingold KR, Marshall M., Gulli R., Moser AH, Grunfeld C. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb 1994; 14: 1866-1872.
36. Popa C., Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007; 48: 751-762.
37. Ettinger WH, Varma VK, Sorci-Thomas M. et al. Cytokines decrease apolipoprotein accumulation in medium from HepG2 cells. Arterioscler Thromb 1994; 14: 8-13.
38. Kutteh WH, Rainey WE, Carr BR Regulatory effects of multifunctional cytokines and steroid hormones on apolipoprotein B production by human fetal hepatocytes. J Soc Gynecol Investig 1994; 1: 256-263.
39. Smedsrod B., Pertoft H. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J Leukoc Biol 1985; 38: 213-230.
40. Hansen B., Arteta B., Smedsrod B. The physiological scavenger receptor function of hepatic sinusoidal endothelial and Kupffer cells is independent of scavenger receptor class A type I and II. Mol Cell Biochem 2002; 240: 1-8.
41. Isusi E., Aspichueta P., Liza M. et al. Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes. Atherosclerosis 2000; 153: 283-294.
42. Ruiz JI, Ochoa B. Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. J Lipid Res 1997; 38: 1482-1489.
43. Tamaki T., Nakai T., Yamaue H. Fructose-1,6-bisphosphate inhibits excess activation of Kupffer cell function induced by endotoxin. Dig Dis Sci 2002; 47: 2179-2185.
44. Dahle MK, Overland G., Myhre AE et al. The phosphatidylinositol 3-kinase/ protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun 2004; 72: 5704-5711.
45. Yao HW, Li J., Chen JQ, Xu SY A 771726, the active metabolite of leflunomide, inhibits TNF-α and IL-1 from Kupffer cells. Inflammation 2004; 28: 97-103.
46. Takemoto Y. Dose effects of propofol on hemodynamic and cytokine responses to endotoxemia in rats. J Anesth 2005; 19: 40-44.
47. Valatas V., Kolios G., Manousou P. et al. Secretion of inflammatory mediators by isolated rat Kupffer cells: The effect of octreotide. Regul Pept 2004; 120: 215-225.
48. Fisher EA, Pan M., Chen X. et al. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J Biol Chem 2001; 276: 27855-27863.
49. Neyrinck AM, Margagliotti S., Gomez C., Delzenne NM Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue. Cell Biochem Funct 2004; 22: 327-332.
50. Roth S., Gong W., Gressner AM Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cells. J Hepatol 1998; 29: 915-922.
51. Alexander B. The role of nitric oxide in hepatic metabolism. Nutrition 1998; 14: 376-390.
52. Kozlov AV, Gille L., Miller I. et al. Opposite effects of endotoxin on mitochondrial and endoplasmic reticulum functions. Biochem Biophys Res Commun 2007; 352: 91-96.
53. α nitroarginine elevates serum very low density lipoprotein and hepatic triglyceride synthesis in rats. J Nutr Biochem 1999; 10: 274-278.
54. Pan M., Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 2004; 113: 1277-1287.
55. Lankester DL, Brown AM, Zammit VA Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes. J Lipid Res 1998; 39: 1889-1895.
56. Brass EP, Vetter WH Interleukin-6, but not tumour necrosis factor-α, increases lipogenesis in rat hepatocyte primary cultures. Biochem J 1994; 301: 193-197.
57. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003; 44: 2339-2348.
58. Memon RA, Holleran WM, Moser AH et al. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol 1998; 18: 1257-1265.
59. Lu B., Sims PJ, Wiedmer T. et al. Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. Biochim Biophys Acta 2007; 1771: 1177-1185.